Open access publisher BioMed Central, UK, has announced that its new journal, Open Network Biology, is now accepting submissions.
Understanding the complex interactions that underlie human disease is key to developing better targets for new drug discoveries and more personalised healthcare for patients. With the age of blockbuster drugs coming to an end, there is a growing need for open collaboration and data sharing to continue progress in the fight against serious disease. Open Network Biology aims to facilitate this goal by publishing network-based models of living systems linked to the corresponding coherent datasets upon which the models are based. The models and associated datasets will be fully available to all, allowing a broad readership to expand the models towards a more complete understanding of the complex phenotypes.
These models are a new type of article which describe in short form the vital basis of network biology, which is the integration of a diversity of high-dimensional, large scale data with clinical data that inform on disease. In addition to articles describing these large data sets, the journal also welcomes submissions of original research, software and methods, along with reviews and commentary, relevant to the emerging field of network biology.
The journal joins the recently-announced GigaScience in providing its authors with a dedicated, open access repository for the data supporting their publications, and complements BioMed Central's growing portfolio of journals that aim to make supporting data a first class citizen in science publishing.
Search for more Open access Journals
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
